ICATIBANT
Manner of administration:Injection
Restriction
Indication: Anticipated emergency treatment of an acute attack of hereditary angioedema
Treatment phase: Initial
Restriction
Indication: Anticipated emergency treatment of an acute attack of hereditary angioedema
Treatment phase: Continuing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $483.95 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||